HKU COVID-19 vaccine trials to start in July
Share - WeChat

A COVID-19 vaccine developed by the University of Hong Kong is expected to begin human trials in July, according to He Yiwu, who leads the HKU vaccine team. However, he told China Daily on Monday that border control could slow down the vaccine manufacturing process as the city must rely on mainland manufacturers. He called for a green channel to facilitate mainland-Hong Kong collaboration in vaccine development.
- New international body for mediation formed in Hong Kong
- Bogota to present Shanghai Award, a first for South America
- Chinese researchers make breakthrough in scanning the universe
- Aerial photos reveal Guizhou's dramatic karst landscape
- Guizhou's Huanggang village named on UN Best Tourism Village list
- Gansu's first captive-born panda cub turns one month old